Adventist HealthCare Shady Grove Medical Center is a 266-licensed bed acute care facility located in Rockville, Maryland.

There are 443 beds in Shady Grove Adventist Hospital.

During the past decade, Shady Grove Adventist Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shady Grove Adventist Hospital" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Johns Hopkins University" with 2 trials sponsored, "American Heart Association" with 1 trials sponsored, "Biotronik, Inc." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shady Grove Adventist Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Duke Clinical Research Institute" with 2 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Karolinska University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Shady Grove Adventist Hospital" are "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Angina" (1 trials), "Angina Pectoris" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Shady Grove Adventist Hospital" in a lesser frequency.

Most popular intervention types in "Shady Grove Adventist Hospital" are "Drug" (9 trials), "Other" (5 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Antroquinonol" (1 trials), "Apixaban 2.5 MG" (1 trials), "CRT-D System" (1 trials) and "Device Replacement with Upgrade" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shady Grove Adventist Hospital" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Shady Grove Adventist Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Shady Grove Adventist Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Shady Grove Adventist Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".